I support removal of the current requirement that a physician’s name be included on prescriptions for Schedule II-V medications.  PAs already have prescriptive authority at the state level and DEA via licensure. PAs undergo pharmacological education both during initial training and through ongoing CME.  Requiring a physician name on a prescription serves no meaningful purpose and creates unnecessary administrative burden.  In the scenario of EMR downtimes or network issues, it creates delays in patient care when pharmacists are made to contact PA prescribers when the physician’s name is missing.